Document is current
Any future updates will be listed below
-
Authors
Cordella, Stefano
Parisotto, Angelica
Bettelli, Francesca
Morselli, Monica
Barbieri, Emiliano
Pozzi, Stefano
Aquilino, Anna
Repaci, Gianluca
Cuoghi, Angela
Bresciani, Paola
Messerotti, Andrea
Colasante, Corrado
Gilioli, Andrea
Pioli, Valeria
Giusti, Davide
Colaci, Elisabetta
Cassanelli, Luca
Ceccherelli, Giovanni
Bevini, Mirco
Malavolti, Roberta
Venturelli, Donatella
Paolini, Ambra
Martinelli, Silvia
Maffei, Rossana
Riva, Giovanni
Nasillo, Vincenzo
Trenti, Tommaso
Comoli, Patrizia
Tagliafico, Enrico
Manfredini, Rossella
Barozzi, Patrizia
Potenza, Leonardo
Marasca, Roberto
Luppi, Mario
Forghieri, Fabio https://orcid.org/0000-0002-6891-1420
- License Information
-
More Information
Article History
Received: 27 June 2022
Accepted: 10 October 2022
First Online: 20 October 2022
Declarations
:
: FF served on advisory boards for Janssen and Novartis and received travel grants from Jazz Pharmaceuticals and Sanofi. ML served on advisory boards for Novartis, AbbVie, Jazz Pharmaceuticals, Gilead Sci., MSD, Sanofi, Daiichi-Sankyo, and Grifols and received travel grants from Gilead Sci and Sanofi. RobMar received research funding from Janssen and Gilead Sciences and honoraria from Gilead Sciences, Janssen, Abbvie, Roche, and Shire. The other authors have no competing interests to declare that are relevant to the content of this article.
